Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Double Blind, Randomized, Controlled Study to Evaluate CHF 5633 (Synthetic Surfactant) and Poractant Alfa in Neonates With Respiratory Distress Syndrome (RDS) (POC)

ClinicalTrials.gov ID: NCT02452476

Public ClinicalTrials.gov record NCT02452476. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A DOUBLE BLIND, RANDOMIZED, CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF SYNTHETIC SURFACTANT (CHF 5633) IN COMPARISON TO PORCINE SURFACTANT (PORACTANT ALFA, CUROSURF®) IN THE TREATMENT OF PRETERM NEONATES WITH RESPIRATORY DISTRESS SYNDROME

Study identification

NCT ID
NCT02452476
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Chiesi Farmaceutici S.p.A.
Industry
Enrollment
123 participants

Conditions and interventions

Interventions

  • CHF5633 Drug
  • Poractant alfa Drug

Drug

Eligibility (public fields only)

Age range
1 Hour to 24 Hours
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 20, 2016
Primary completion
May 23, 2018
Completion
May 23, 2018
Last update posted
Aug 12, 2021

2016 – 2018

United States locations

U.S. sites
23
U.S. states
16
U.S. cities
23
Facility City State ZIP Site status
University of South Alabama - USA Children's and Women's Hospital Mobile Alabama
LAC + USC Medical Center, Keck School of Medicine Los Angeles California
UC Irvine Medical Center Orange California
Sharp Mary Birch Hospital San Diego California
Connecticut Children's Medical Center Hartford Connecticut
Plantation General Hospital (Sheridan Clinical Research, Inc.) Plantation Florida
Jatinder Bhatia Augusta Georgia
Indiana University School of Medicine Indianapolis Indiana
Memorial Hospital of South Bend South Bend Indiana
University of Louisville Research Foundation, Inc. Louisville Kentucky
Floating Hospital for Children at Tufts Medical Center Boston Massachusetts 02111
Baystate Children's Hospital / Baystate Medical Center Springfield Massachusetts
Winthrop University Hospital Mineola New York
Kings County Hospital Center New York New York
Sergio G. Golombek Valhalla New York
Martha Naylor Greenville North Carolina
Cincinnati Children's Hospital Medical Center Cincinnati Ohio
Case Western Reserve University Cleveland Ohio
Krishnamurthy Sekar Oklahoma City Oklahoma
Hahnemann University Hospital Philadelphia Pennsylvania
Texas Tech University Health Sciences Center El Paso Texas
MultiCare Institute for Research & Innovation Tacoma Washington
West Virginia University Morgantown West Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02452476, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 12, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02452476 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →